New hope for Tough-to-Treat leukemia: drug trial aims to wipe out hidden cancer cells

This study is testing whether a drug called daratumumab can help adults with a hard-to-treat type of leukemia called T-cell acute lymphoblastic leukemia (T-ALL). It's for patients who have finished standard chemotherapy but still have tiny amounts of cancer cells left, which raises the risk of the cancer coming back. Researchers will give daratumumab to up to 20 participants to see if it can clear these remaining cells and help keep the cancer in remission.